Temporal Interference Stimulation for Children with Autism
Official title: Individualized Targeted Transcranial Temporal Interference Stimulation for Children With Autism Spectrum Disorder: A Single-Blinded, Randomized, Controlled Exploratory Trial
Run by Xinhua Hospital, Shanghai Jiao Tong University School of Medicine · NCT07625748 · Data updated 2026-11-12
This study tests whether a noninvasive brain stimulation method (tTIS) is safe and tolerable for children with autism aged 4–10.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 4 Years to 10 Years |
| Sex | All |
| Enrollment | 16 (estimated) |
| Sponsor | Xinhua Hospital, Shanghai Jiao Tong University School of Medicine Academic / other |
| Locations | 1 site (Shanghai, Shanghai Municipality) |
| Status | Recruiting |
| Started | May 25, 2026 |
| Main results expected | September 30, 2026 |
| Study ends | October 5, 2026 |
| Registry record updated | June 4, 2026 |
| Trial ID | NCT07625748 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Children aged 4–10 years with a DSM-5/ADI-R/ADOS-confirmed ASD and an FSIQ of at least 50 who have parental consent.
✕Probably not a fit
Participants with metal implants, epilepsy, structural brain abnormalities requiring surgery, genetic syndromes, significant mental illness, severe cardiac disease, high intracranial pressure, or those in another trial or recent protocol changes may not benefit.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This is a 5-week, single-blinded, randomized trial enrolling 16 children with autism to compare temporal interference stimulation (tTIS) against a sham control over five consecutive days. Participants in the active arm receive 1.5 mA stimulation at 2040/2000 Hz with a 40 Hz envelope for 20 minutes per session, while the sham group receives identical setup without the 40 Hz envelope. Primary outcomes focus on safety, tolerability, completion rate, and protocol adherence, with secondary outcomes including change in SRS-2 scores from baseline to end of treatment and to four weeks post-intervention. Assessments include baseline measurements, IQ testing, clinical scales, and resting-state EEG, with follow-up on symptoms, imaging, and adverse events through four weeks after completion. The study aims to determine feasibility of tTIS in pediatric ASD and to gather preliminary signals on social responsiveness changes.
Why it matters
Potential benefit: If successful, tTIS could become a feasible, noninvasive option that may help improve social responsiveness in children with ASD.
How similar studies have gone: Prior noninvasive brain stimulation approaches in pediatric ASD have shown mixed feasibility and safety signals; this study addresses feasibility and safety for tTIS in this population.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Children aged 4-10 years * Meeting the diagnostic criteria for ASD according to the Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (DSM-5) and confirmed by the Autism Diagnostic Observation Schedule (ADOS) and/or the Autism Diagnostic Interview-Revised (ADI-R) * Full Scale Intelligence Quotient (FSIQ) ≥50 * Signed informed consent form Exclusion Criteria: * Individuals with metal implants in the body * Individuals with neurological disorders such as epilepsy * Those requiring surgical treatment due to structural abnormalities indicated by brain MRI examination * Those diagnosed with genetic or chromosomal abnormalities * Individuals with mental illness (such as early-onset schizophrenia) * Those with severe cardiac disease * Individuals with increased intracranial pressure * Those currently participating in other clinical trials * Those who received new intervention protocols within 4 weeks prior to enrollment.
Where it's running
-
Fei Li
Shanghai, Shanghai Municipality, China Recruiting
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Sensory Integration and Deep Pressure Therapy for Motor Coordination in Children with ASD
This study tests whether combining Sensory Integration Therapy with Deep Pressure Therapy can improve motor coordination and reduce repetitive behaviors in children aged 4–10 with autism.
-
Pupillometer screen to help identify autism in kids aged 2–4 during routine visits
A handheld pupillometer test is being tried to see if it can help identify autism in young children during regular pediatric visits.
-
Leopard: using multi-omics to boost genetic diagnosis for neurodevelopmental disorders
This study tests a multi-omics approach to find genetic explanations for neurodevelopmental disorders in people with moderate-to-severe intellectual disability.
-
Heart Rate Variability Biofeedback for Anxiety in Autistic Youth
This study tests a wearable heart rate variability biofeedback tool to see if it helps reduce anxiety in autistic teens.
-
Structured Sensory-Based Occupational Therapy for Children with Autism
This study tests a 12-week, 40-minute sensory-based occupational therapy program twice a week to see if it improves daily skills, sensory processing, movement, and eating in children aged 3-9 with autism.
-
Exergaming and Aerobic Exercise for Kids with Autism
This study tests whether adding exergames or aerobic exercise to a standard program helps improve sleep, movement skills, thinking skills, and brain activity in children with autism.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.